Shilpa Keerthivasan to Drug Resistance, Neoplasm
This is a "connection" page, showing publications Shilpa Keerthivasan has written about Drug Resistance, Neoplasm.
Connection Strength
0.173
-
Single-Cell RNA Sequencing Reveals Stromal Evolution into LRRC15+ Myofibroblasts as a Determinant of Patient Response to Cancer Immunotherapy. Cancer Discov. 2020 02; 10(2):232-253.
Score: 0.137
-
High systemic and tumor-associated IL-8 correlates with reduced clinical benefit of PD-L1 blockade. Nat Med. 2020 05; 26(5):693-698.
Score: 0.036